Table 1.
Demographic and clinical characteristics.
| SZP (n = 21) | MDD (n = 25) | Controls (n = 28) | pa | |
|---|---|---|---|---|
| Age (years) | 34.0(12.3) | 48.8 (14.8) | 42.0(17.5) | <0.05 |
| Sex (f/m) | 11/10 | 13/12 | 18/10 | |
| PANSS, total | 80.8(20.8) | 35.2 (3.4) | 30.7(0.8) | <0.01 |
| PANSS, positive | 19.1(5.9) | 7.8 (1.1) | 7.29(0.53) | <0.01 |
| PANSS, negative | 19.1(6.1) | 10.0 (2.3) | 7.32(0.55) | <0.01 |
| HAM-D | 9.0(5.9) | 22 (7.1) | 0.9(1.1) | <0.01 |
| GAF | 41.5 (11.6) | 50 (10.5) | 99.5 (1.1) | <0.01 |
a
Statistical testing was based on ANOVA. Abbreviations: SZP schizophrenia; MDD major depressive disorder; PANSS, Positive and Negative Syndrome Scale; Ham-D Hamilton depression scale; GAF Global Assessment of Functioning Scale.